Abbott Sues Impax Over Depakote

Law360, New York (June 20, 2007, 12:00 AM EDT) -- Abbott Laboratories filed a patent suit Monday against generics maker Impax Laboratories Inc., increasing its efforts to protect the multimillion-dollar U.S. market for its epilepsy and migraine treatment Depakote.

In a complaint filed in the U.S. District Court for the District of Delaware, Abbott alleged that a recent abbreviated new drug application filed by Impax with the U.S. Food and Drug Administration infringed two patents for Depakote ER, the extended release version of its blockbuster drug. Abbott asserted one of the patents in a similar suit...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.